A detailed history of Simplex Trading, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 47,110 shares of ACAD stock, worth $696,756. This represents 0.03% of its overall portfolio holdings.

Number of Shares
47,110
Previous 57,376 17.89%
Holding current value
$696,756
Previous $1.06 Million 27.83%
% of portfolio
0.03%
Previous 0.03%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$14.62 - $18.42 $150,088 - $189,099
-10,266 Reduced 17.89%
47,110 $765,000
Q1 2024

Apr 25, 2024

SELL
$17.79 - $30.86 $53,174 - $92,240
-2,989 Reduced 4.95%
57,376 $1.06 Million
Q4 2023

Feb 02, 2024

SELL
$20.78 - $31.77 $395,297 - $604,360
-19,023 Reduced 23.96%
60,365 $1.89 Million
Q3 2023

Nov 01, 2023

BUY
$20.84 - $33.47 $1.65 Million - $2.66 Million
79,388 New
79,388 $1.65 Million
Q4 2022

Feb 02, 2023

SELL
$14.2 - $18.63 $134,928 - $177,022
-9,502 Reduced 64.19%
5,300 $84,000
Q3 2022

Nov 04, 2022

BUY
$14.11 - $18.27 $134,073 - $173,601
9,502 Added 179.28%
14,802 $242,000
Q2 2022

Aug 03, 2022

SELL
$13.01 - $27.22 $153,518 - $321,196
-11,800 Reduced 69.01%
5,300 $74,000
Q1 2022

May 02, 2022

SELL
$20.94 - $27.5 $1.45 Million - $1.91 Million
-69,293 Reduced 80.21%
17,100 $414,000
Q4 2021

Feb 23, 2022

BUY
$16.79 - $27.09 $588,338 - $949,260
35,041 Added 68.24%
86,393 $2.02 Million
Q3 2021

Oct 28, 2021

BUY
$15.78 - $24.77 $3,156 - $4,954
200 Added 0.39%
51,352 $1.27 Million
Q2 2021

Aug 12, 2021

SELL
$19.4 - $27.42 $770,277 - $1.09 Million
-39,705 Reduced 43.7%
51,152 $1.25 Million
Q1 2021

Apr 26, 2021

BUY
$25.02 - $54.99 $1.73 Million - $3.81 Million
69,239 Added 320.28%
90,857 $2.34 Million
Q4 2020

Feb 02, 2021

SELL
$41.04 - $56.79 $17,524 - $24,249
-427 Reduced 1.94%
21,618 $0
Q3 2020

Oct 14, 2020

BUY
$36.42 - $57.0 $802,878 - $1.26 Million
22,045 New
22,045 $0
Q2 2020

Jul 13, 2020

SELL
$39.26 - $52.73 $425,342 - $571,276
-10,834 Closed
0 $0
Q1 2020

Apr 29, 2020

SELL
$31.65 - $46.87 $507,033 - $750,857
-16,020 Reduced 59.66%
10,834 $457,000
Q4 2019

Feb 05, 2020

SELL
$36.21 - $51.4 $1.48 Million - $2.11 Million
-40,966 Reduced 60.4%
26,854 $1.15 Million
Q3 2019

Oct 15, 2019

BUY
$22.22 - $44.01 $772,700 - $1.53 Million
34,775 Added 105.24%
67,820 $0
Q2 2019

Jul 26, 2019

SELL
$23.32 - $28.12 $819,371 - $988,024
-35,136 Reduced 51.53%
33,045 $883,000
Q1 2019

Apr 18, 2019

BUY
$16.17 - $27.38 $546,626 - $925,580
33,805 Added 98.34%
68,181 $0
Q4 2018

Jan 16, 2019

SELL
$14.32 - $22.92 $9,981 - $15,975
-697 Reduced 1.99%
34,376 $555,000
Q3 2018

Oct 23, 2018

BUY
$13.03 - $21.81 $124,110 - $207,740
9,525 Added 37.28%
35,073 $728,000
Q2 2018

Jul 30, 2018

BUY
$15.07 - $22.34 $385,008 - $570,742
25,548 New
25,548 $390,000
Q1 2018

Apr 26, 2018

SELL
$22.47 - $32.33 $226,430 - $325,789
-10,077 Closed
0 $0
Q4 2017

Jan 10, 2018

SELL
$26.84 - $39.14 $299,239 - $436,371
-11,149 Reduced 52.53%
10,077 $303,000
Q3 2017

Oct 25, 2017

BUY
$29.49 - $38.37 $625,954 - $814,441
21,226
21,226 $799,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.